S&P 500   5,076.25 (-0.25%)
DOW   39,082.09 (-0.13%)
QQQ   438.08 (+0.30%)
AAPL   181.22 (-0.71%)
MSFT   409.39 (-0.23%)
META   484.56 (+0.11%)
GOOGL   138.41 (-3.86%)
AMZN   174.90 (-0.05%)
TSLA   200.66 (+4.53%)
NVDA   802.38 (+1.80%)
NIO   5.61 (+3.89%)
AMD   176.80 (+0.16%)
BABA   76.24 (+0.37%)
T   16.58 (-1.31%)
F   12.06 (-0.66%)
MU   90.92 (+5.72%)
CGC   3.48 (+3.57%)
GE   154.57 (+0.81%)
DIS   107.95 (+0.19%)
AMC   4.61 (+3.83%)
PFE   27.09 (-2.41%)
PYPL   59.60 (+0.74%)
XOM   104.69 (+0.82%)
S&P 500   5,076.25 (-0.25%)
DOW   39,082.09 (-0.13%)
QQQ   438.08 (+0.30%)
AAPL   181.22 (-0.71%)
MSFT   409.39 (-0.23%)
META   484.56 (+0.11%)
GOOGL   138.41 (-3.86%)
AMZN   174.90 (-0.05%)
TSLA   200.66 (+4.53%)
NVDA   802.38 (+1.80%)
NIO   5.61 (+3.89%)
AMD   176.80 (+0.16%)
BABA   76.24 (+0.37%)
T   16.58 (-1.31%)
F   12.06 (-0.66%)
MU   90.92 (+5.72%)
CGC   3.48 (+3.57%)
GE   154.57 (+0.81%)
DIS   107.95 (+0.19%)
AMC   4.61 (+3.83%)
PFE   27.09 (-2.41%)
PYPL   59.60 (+0.74%)
XOM   104.69 (+0.82%)
S&P 500   5,076.25 (-0.25%)
DOW   39,082.09 (-0.13%)
QQQ   438.08 (+0.30%)
AAPL   181.22 (-0.71%)
MSFT   409.39 (-0.23%)
META   484.56 (+0.11%)
GOOGL   138.41 (-3.86%)
AMZN   174.90 (-0.05%)
TSLA   200.66 (+4.53%)
NVDA   802.38 (+1.80%)
NIO   5.61 (+3.89%)
AMD   176.80 (+0.16%)
BABA   76.24 (+0.37%)
T   16.58 (-1.31%)
F   12.06 (-0.66%)
MU   90.92 (+5.72%)
CGC   3.48 (+3.57%)
GE   154.57 (+0.81%)
DIS   107.95 (+0.19%)
AMC   4.61 (+3.83%)
PFE   27.09 (-2.41%)
PYPL   59.60 (+0.74%)
XOM   104.69 (+0.82%)
S&P 500   5,076.25 (-0.25%)
DOW   39,082.09 (-0.13%)
QQQ   438.08 (+0.30%)
AAPL   181.22 (-0.71%)
MSFT   409.39 (-0.23%)
META   484.56 (+0.11%)
GOOGL   138.41 (-3.86%)
AMZN   174.90 (-0.05%)
TSLA   200.66 (+4.53%)
NVDA   802.38 (+1.80%)
NIO   5.61 (+3.89%)
AMD   176.80 (+0.16%)
BABA   76.24 (+0.37%)
T   16.58 (-1.31%)
F   12.06 (-0.66%)
MU   90.92 (+5.72%)
CGC   3.48 (+3.57%)
GE   154.57 (+0.81%)
DIS   107.95 (+0.19%)
AMC   4.61 (+3.83%)
PFE   27.09 (-2.41%)
PYPL   59.60 (+0.74%)
XOM   104.69 (+0.82%)

Navidea Biopharmaceuticals (NAVB) SEC Filings & 10K Form

$0.04
0.00 (-4.44%)
(As of 12:33 PM ET)

Recent Navidea Biopharmaceuticals SEC Filings

DateFilerForm TypeView
02/05/2024
6:53 PM
Navidea Biopharmaceuticals (Subject)
Scott John K Jr. (Filed by)
Form SC 13D/A
01/31/2024
11:15 PM
Navidea Biopharmaceuticals (Filer)
Form EFFECT
01/31/2024
11:15 PM
Navidea Biopharmaceuticals (Filer)
Form EFFECT
01/31/2024
11:15 PM
Navidea Biopharmaceuticals (Filer)
Form EFFECT
01/31/2024
11:15 PM
Navidea Biopharmaceuticals (Filer)
Form EFFECT
01/31/2024
11:15 PM
Navidea Biopharmaceuticals (Filer)
Form EFFECT
01/26/2024
4:26 PM
Navidea Biopharmaceuticals (Filer)
Form POS AM
01/26/2024
4:27 PM
Navidea Biopharmaceuticals (Filer)
Form S-8 POS
01/26/2024
4:27 PM
Navidea Biopharmaceuticals (Filer)
Form POS AM
01/26/2024
4:27 PM
Navidea Biopharmaceuticals (Filer)
Form S-8 POS
01/26/2024
4:27 PM
Navidea Biopharmaceuticals (Filer)
Form POS AM
01/26/2024
4:27 PM
Navidea Biopharmaceuticals (Filer)
Form S-8 POS
01/26/2024
4:27 PM
Navidea Biopharmaceuticals (Filer)
Form POS AM
01/26/2024
4:27 PM
Navidea Biopharmaceuticals (Filer)
Form S-8 POS
01/26/2024
4:28 PM
Navidea Biopharmaceuticals (Filer)
Form S-8 POS
01/26/2024
4:28 PM
Navidea Biopharmaceuticals (Filer)
Form S-8 POS
01/26/2024
4:28 PM
Navidea Biopharmaceuticals (Filer)
Form S-8 POS
01/16/2024
12:53 PM
Navidea Biopharmaceuticals (Subject)
NYSE AMERICAN LLC (Filed by)
Form 25-NSE
12/22/2023
6:54 PM
Navidea Biopharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/21/2023
2:32 PM
Navidea Biopharmaceuticals (Subject)
Scott John K Jr. (Filed by)
Form SC 13D/A
12/05/2023
5:26 PM
Navidea Biopharmaceuticals (Issuer)
Scott John K Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
10:49 AM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2023
5:43 PM
Moss Dana J (Reporting)
Navidea Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
5:10 PM
Navidea Biopharmaceuticals (Issuer)
Stefanelli Jill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2023
3:55 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
1:58 PM
Navidea Biopharmaceuticals (Filer)
Form DEFA14A
10/23/2023
12:56 PM
Navidea Biopharmaceuticals (Subject)
NYSE AMERICAN LLC (Filed by)
Form 25-NSE
10/05/2023
3:21 PM
Navidea Biopharmaceuticals (Filer)
Form DEF 14A
09/15/2023
2:42 PM
Navidea Biopharmaceuticals (Filer)
Form PRE 14A
09/10/2023
11:15 PM
Navidea Biopharmaceuticals (Filer)
Form EFFECT
08/15/2023
4:53 PM
Dais Craig (Reporting)
Navidea Biopharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/11/2023
3:06 PM
Navidea Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/17/2023
5:00 PM
Moss Dana J (Reporting)
Navidea Biopharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/17/2023
5:02 PM
Moss Dana J (Reporting)
Navidea Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/13/2023
4:27 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/06/2023
3:39 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2023
4:30 PM
Navidea Biopharmaceuticals (Filer)
Form DEF 14A
07/03/2023
3:01 PM
Bain Irwin Allen (Filed by)
Navidea Biopharmaceuticals (Subject)
Form SC 13G/A
06/30/2023
9:46 AM
Navidea Biopharmaceuticals (Issuer)
Scott John K Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
4:22 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2023
4:24 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2023
4:26 PM
Navidea Biopharmaceuticals (Filer)
Form PRE 14A
06/16/2023
3:20 PM
Navidea Biopharmaceuticals (Subject)
Scott John K Jr. (Filed by)
Form SC 13D/A
06/15/2023
5:35 PM
Navidea Biopharmaceuticals (Issuer)
Scott John K Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
10:03 AM
Navidea Biopharmaceuticals (Issuer)
Stefanelli Jill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
1:41 PM
Navidea Biopharmaceuticals (Issuer)
Stefanelli Jill (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/28/2023
9:55 AM
Navidea Biopharmaceuticals (Filer)
Form 424B5
04/28/2023
9:56 AM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/13/2023
4:24 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2023
4:20 PM
Navidea Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2023
3:31 PM
Navidea Biopharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:NAVB) was last updated on 2/26/2024 by MarketBeat.com Staff